Previous Close | 368.18 |
Open | 364.22 |
Bid | 352.77 x 800 |
Ask | 360.79 x 800 |
Day's Range | 358.89 - 370.00 |
52 Week Range | 310.42 - 415.73 |
Volume | |
Avg. Volume | 545,301 |
Market Cap | 26.385B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 47.61 |
EPS (TTM) | 7.57 |
Earnings Date | Jul 25, 2024 - Jul 29, 2024 |
Forward Dividend & Yield | 0.80 (0.22%) |
Ex-Dividend Date | Jul 31, 2024 |
1y Target Est | 403.29 |
West Pharmaceutical Services ( NYSE:WST ) First Quarter 2024 Results Key Financial Results Revenue: US$695.4m (down...
Despite a dip in Q1 performance, West Pharmaceutical projects a robust year with strategic expansions and improved guidance.
West Pharmaceutical's (WST) first-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.